Supporting this notion, Ferrari-Cestari et al. recently demonstrated that CCL2 production in MASLD is more strongly associated with the degree of visceral adiposity rather than fibrosis [29]. This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatotic liver disease.